Resolve Biosciences
Germany-based molecular cartography technology company
Resolve Biosciences has raised €72M across 1 funding round from 5 investors, most recently a Series B round in Oct 2022. Based in Munich, Germany; active in Healthtech. Data as of 28 Oct 2026.
Munich, Germanyresolvebiosciences.com ↗
Total raised
€72M
€72,073,901
Funding rounds
1
Investors
5
distinct backers
Active since
2022-10
latest 2022-10
Funding by year
EUR raised per yearResolve Biosciences — funding by year — interactive chart.
Data table
| Resolve Biosciences — funding by year | |
|---|---|
| 2022 | €72M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-24 | Series B | €72M | Alafi Capital,EDBI,NRW.BANK,Patient Square Capital,PS Capital | View deal → |
Related news
- Resolve Biosciences Raises $71M in Series B Financingfinsmes.com · 2022-10
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData